Table 4. Patients’ evolution depending on the time from first medical visit to first ART prescription (classes by quartiles).
| Time from first medical visit to first ART (days) | < 9 N = 1881 |
9–27 N = 1784 |
28–90 N = 1800 |
> 90 N = 1780 |
P | |
|---|---|---|---|---|---|---|
| Alive and in care at month 12 after ART prescription (%) | 79.9 | 84.5 | 85.9 | 85.2 | <0.0001 | |
| Time from diagnosis to undetectable VL (days; median, IQR) | 194 (108–351) | 210 (130–361) | 232 (152–357) | 527 (311–924) | <0.0001 | |
| Length of first ART (months; median, IQR) | 14 (5–32) | 17 (7–35) | 21.5 (7–39) | 22 (7–42) | <0.0001 | |
| End of study situation | Dead (%) | 2.2 | 3.1 | 1.9 | 0.9 | 0.002 |
| LTFU (%) | 14.3 | 12.4 | 13.4 | 12.5 | 0.002 | |
| VL < 50 copies/mL after 6 months of ART (%) | 72.1 | 69.8 | 78.9 | 79.6 | <0.0001 | |
| VL < 50 copies/mL after 12 months of ART (%) | 78.0 | 81.5 | 84.1 | 81.4 | 0.12 | |
| VL < 50 copies/mL after 18 months of ART (%) | 83.7 | 85.5 | 86.9 | 87.9 | 0.15 | |